Regarding trastuzumab, all of the following are true except :: (A) Shows better response in combination with paclitaxel, (B) Used in non-metastatic breast cancer, (C) Causes upregulation of HER2/neu, (D) Do not cause bone marrow toxicity
Answer is C. None